Neural Therapeutics Gains Approval for Strategic Acquisition of German CBD Retailer

Neural Therapeutics Inc. announced that CWE European Holdings Inc. shareholders have approved a Strategic Investment and Option Agreement, allowing Neural to potentially acquire up to 100% of CWE, a leading CBD retailer in Germany. This multi-stage transaction aims to expand Neural’s commercial presence in Europe and aligns with its strategy to develop new mescaline-based mental […]